The U.S. light therapy market size is expected to be valued at US$ 368.2 million in 2026 and is projected to reach US$ 532.1 million, growing at a CAGR of 5.4% between 2026 and 2033. Growing consumer awareness of non-invasive phototherapy solutions for dermatological, musculoskeletal, and mood-related conditions remains the primary driver of market expansion. This momentum is reinforced by the National Institute of Mental Health's estimate that Seasonal Affective Disorder affects a significant proportion of U.S. adults during the winter months, sustaining consistent demand for light box therapy.

Additionally, the U.S. Food and Drug Administration's clearance of an increasing number of at-home phototherapy devices through its 510(k) pathway is strengthening consumer confidence and expanding retail availability, while rising direct-to-consumer wellness spending continues to broaden the addressable market beyond clinical settings.

Driver – Rising Prevalence of Seasonal Affective Disorder and Mood-Related Conditions

The clinical burden of Seasonal Affective Disorder (SAD) remains a key factor driving demand for light therapy. The National Institute of Mental Health estimates that a significant proportion of U.S. adults experience seasonal depressive symptoms, with prevalence notably higher in northern states where winter daylight hours are limited. This continues to drive consistent demand for light boxes and light visors during the fall and winter months, as verified 10,000-lux devices remain a first-line non-pharmacological treatment recommended by the American Psychiatric Association.

Growing physician awareness and increasing discussions around insurance coverage for light therapy as an adjunct treatment are further normalizing its use across hospital and home-care settings, supporting consistent demand and recurring purchase cycles for manufacturers such as Verilux, Inc. and Carex.

Expanding At-Home Red Light and Infrared Therapy Adoption for Skin and Pain Conditions

The rapid shift toward at-home red light and infrared therapy devices is significantly driving market growth. Growing consumer interest in photobiomodulation for skin rejuvenation, muscle recovery, and chronic pain relief has encouraged direct-to-consumer brands including Joovv, Inc., HigherDOSE, and PlatinumLED Therapy Lights to expand their product portfolios for home users.

The U.S. Food and Drug Administration's general wellness device classification for many low-risk red and near-infrared devices has simplified market entry and accelerated commercialization. Fitness enthusiasts, athletes, and aging populations seeking non-invasive pain management alternatives are increasingly incorporating these devices into their daily wellness routines, supported by expanding retail availability through wellness and specialty health channels across the U.S.

Restraint – High Device Costs and Limited Insurance Reimbursement

Premium light therapy devices, particularly full-body infrared panels and clinical-grade phototherapy units, often carry price points exceeding several hundred dollars, creating an affordability barrier for cost-sensitive consumers. Most private insurance plans and Medicare do not classify at-home light therapy devices as reimbursable durable medical equipment, placing the entire cost burden on patients. This limited reimbursement discourages broader adoption among lower-income populations and older adults who are likely to benefit clinically from phototherapy but lack sufficient disposable income for out-of-pocket purchases, thereby constraining the addressable market for premium device categories despite growing clinical acceptance.

Regulatory Ambiguity and Safety Concerns Around Unregulated Devices

The growing availability of low-cost imported light therapy devices sold through online marketplaces without proper U.S. Food and Drug Administration clearance has raised safety and efficacy concerns among clinicians and regulators. Reports of inconsistent light intensity, inadequate eye protection, and unsupported therapeutic claims have increased scrutiny of the aesthetic and wellness device segment. This regulatory uncertainty creates reputational challenges for the broader market, as negative consumer experiences with substandard devices undermine confidence in clinically validated products and complicate marketing efforts for compliant manufacturers competing against low-cost alternatives.

Opportunity – Expansion of Telehealth-Integrated Home Phototherapy Programs

The expanding integration of telehealth platforms with home-based phototherapy programs presents a significant growth opportunity for both device manufacturers and healthcare providers. Dermatology and behavioral health practices are increasingly prescribing home light therapy regimens supported by remote monitoring, reducing the need for in-clinic visits while maintaining treatment oversight. This approach aligns with broader U.S. telehealth adoption, supported by the Centers for Medicare & Medicaid Services through extended telehealth flexibilities introduced after the pandemic.

Companies such as Zerigo Health, which specialize in connected phototherapy devices with remote monitoring capabilities, are well positioned to benefit as dermatology practices increasingly adopt technology-enabled treatment models. Manufacturers investing in app-connected devices featuring usage tracking and provider dashboards are expected to strengthen product differentiation and competitiveness within the market.

Growing Demand for Red and Near-Infrared Therapy in Sports Recovery and Aging Wellness

The convergence of sports recovery science and anti-aging wellness trends is creating immense growth opportunities for manufacturers of red and near-infrared light therapy devices. Professional and amateur athletes are increasingly adopting photobiomodulation to support muscle recovery and reduce inflammation, supported by expanding research into its effects on cellular energy production. At the same time, the growing aging population in the U.S. is driving demand for non-invasive skin rejuvenation and joint pain management solutions, increasing adoption of infrared and near-infrared devices across both clinical and home settings.

Brands such as Sunlighten Inc. and Mito Red Light LLC have expanded their infrared panel portfolios to address this dual-use demand, reflecting the rapid maturation of the category. Manufacturers that position their products around clinically validated wellness outcomes rather than broad marketing claims are expected to capture sustained demand and strengthen long-term sales growth throughout the forecast period.

Product Insights

Light boxes are expected to hold the largest share of 35% in the U.S. light therapy market in 2026, owing to their status as the clinically preferred first-line treatment for Seasonal Affective Disorder (SAD). Backed by decades of research validating the therapeutic effectiveness of 10,000-lux light intensity, light boxes remain the most commonly recommended devices by mental health professionals and primary care physicians. Their relatively lower price point compared with specialized handheld or panel devices, combined with ease of use in home settings, supports broad consumer accessibility.

Established brands such as Verilux, Inc., Carex, and NatureBright have built strong retail and e-commerce distribution networks for light boxes, reinforcing consumer awareness and market penetration. While handheld and red-light devices continue gaining traction in wellness-focused applications, light boxes retain their leading position due to their clinically validated effectiveness for the treatment of SAD.

Handheld devices represent the fastest-growing product segment in the U.S. light therapy market, driven by increasing consumer demand for portable, convenient, and home-based treatment solutions. Their compact design, affordability, and expanding use for pain management, muscle recovery, skin rejuvenation, and wound healing make them attractive to both wellness-focused consumers and patients seeking non-invasive therapies. Growing availability through e-commerce platforms and continuous product innovations, including rechargeable and app-connected devices, are further accelerating segment growth.

Light Type Insights

Red light is expected to lead the U.S. light therapy market with an estimated 34% share in 2026, driven by its broad application across skin rejuvenation, pain management, and general wellness. Clinical research published in dermatology and photobiomodulation journals has consistently demonstrated red light's ability to stimulate collagen production and reduce inflammation, strengthening its credibility beyond cosmetic applications. This scientific evidence has accelerated adoption among both healthcare providers and direct-to-consumer wellness brands, including Joovv, Inc. and PlatinumLED Therapy Lights, which have developed product portfolios focused on red and near-infrared wavelengths.

Red light’s versatility across multiple therapeutic applications, ranging from skin conditions to pain management, enables manufacturers to address diverse consumer needs with a single product category, reinforcing its leadership over more specialized light types such as blue light and infrared light.

End-User Insights

Dermatology clinics are likely to lead the U.S. light therapy market while holding an estimated 34% share in 2026, reflecting their central role in diagnosing and administering phototherapy for chronic skin conditions. These clinics utilize high-intensity, clinical-grade devices that require professional supervision, making them the primary treatment setting for conditions such as psoriasis and vitiligo that require precise dosing protocols.

Reimbursement pathways for clinic-based phototherapy sessions, although limited, remain more established than those for home-use devices, supporting consistent patient volumes at dermatology clinics. Partnerships between device manufacturers such as TheraLight, LLC and dermatology practice networks continue to strengthen this end-user segment, even as home-care settings expand with the increasing availability of consumer-grade light therapy devices.

West U.S. Light Therapy Market Trends and Insights

The West U.S. is likely to dominate the market due to its high concentration of wellness brands, dermatology clinics, and aesthetic treatment centers, particularly in California and the Pacific region. Companies such as Joovv, HigherDOSE, and PlatinumLED Therapy Lights have established a strong regional presence, increasing consumer awareness and adoption of red and near-infrared light therapy devices. High disposable incomes, strong consumer spending on wellness products, and early adoption of health technologies continue to drive demand for premium light therapy solutions. Additionally, increasing investment in innovative home-use devices and expanding collaborations between wellness companies and healthcare providers are expected to further strengthen the area's market leadership throughout the forecast period.

Midwest U.S. Light Therapy Market Trends and Insights

The Midwest U.S. is expected to hold a considerable share of the market in 2026, primarily supported by the high prevalence of Seasonal Affective Disorder (SAD) associated with prolonged winters and limited daylight exposure. Healthcare providers and academic medical centers increasingly incorporate phototherapy into behavioral health and dermatology treatment protocols, while broad retail availability improves product accessibility. Growing consumer awareness of non-pharmacological treatment options continues to support market expansion. Furthermore, increasing physician recommendations and broader insurance coverage for selected phototherapy treatments are expected to sustain regional market growth throughout the forecast period.

Southeast U.S. Light Therapy Market Trends and Insights

The Southeast U.S. is expected to be the fastest-growing market, registering an estimated CAGR of 6.5% between 2026 and 2033. Growth is driven by rapid population growth, an expanding elderly population, and increasing adoption of home healthcare and telehealth services across states such as Florida and Georgia. Expanding dermatology clinic networks, rising investment in wellness services, and increasing consumer spending on preventive healthcare continue to support market expansion. In addition, the growing availability of direct-to-consumer light therapy devices through online retail channels is expected to accelerate product adoption across the area.

The U.S. light therapy market is moderately fragmented, comprising established clinical device manufacturers alongside a growing wave of direct-to-consumer wellness brands. Competitive intensity is increasingly centered on product differentiation through wavelength specificity, app connectivity, and clinically validated efficacy claims rather than price alone. Leading companies such as Sunlighten Inc. and Joovv, Inc. are investing heavily in third-party clinical research partnerships to substantiate therapeutic claims, while newer entrants compete primarily through social media-driven direct marketing and influencer partnerships.

Vertical integration between device manufacturing and telehealth-enabled treatment monitoring, exemplified by companies like Zerigo Health, reflects an emerging business model shift toward outcome-based service offerings rather than standalone hardware sales, reshaping how market leaders position themselves competitively.

Key Industry Developments

• In June 2026, Solbasium announced the launch of the Solbasium Quantum Roller, a patented portable recovery device that integrates myofascial rolling, tissue compression, and dual red and near-infrared light therapy into a single system designed for athletes, clinicians, and wellness users.
• In April 2023, Photopharmics secured US$6 million in funding to advance the Phase 3 clinical trial of its Celeste light therapy device for Parkinson's disease and support pre-commercialization activities ahead of regulatory submission.